A Systematic Review About the Contribution of The Genus Tessaria (Asteraceae) To Cancer Study and Treatment

Belonging to the Asteraceae family, Tessaria (Ruiz & Pavon, 1753) is a genus of shrubs or small trees distributed in various habitats located from Argentina southwestern United States America. The taxa are composed five confirmed species, which have been previously reported for their ethnopharmacological uses as hypocholesterolemiant, hypoglycemic, antitussive, anti-inflammatory, anticancer, and abortifacient agent; it also has used hepatic, renal, pulmonary, rheumatic diseases. Up present, T. absinthioides, ambigua, dodoneifolia, fastigiata integrifolia chemically analyzed. While decoctions, infusions, methanolic, hydromethanolic extracts most studied botanical compounds, its recognized phytochemical constituents caffeoylquinic acid, eupatorin, naringenin, protocatechuic, quercetin. Scientifically, several biomedical properties such virucidal, antibacterial, leishmanicidal, insecticidal, gastroprotective, antiasthmatic, antiatherogenic were attributed genus. Concerning oncologic research, chemicals produced by antitumor activities interfering with carcinogenesis, cell proliferation, metastasis, angiogenesis. In addition, natural obtained species biological closely related cancer, acting antioxidants anti-inflammatories. particular, that absinthioides resulted cytotoxic against cancer lines acts an antitumoral compound murine models. Due aforementioned antecedents, considered undervalued within oncological field; goal current systematic review summarize information available on genus, relevant research treatment.